Add like
Add dislike
Add to saved papers

Real-world Performance of the MiniMed™ 780G System: First Report of Outcomes from 4'120 Users.

BACKGROUND: The MiniMed™ 780G system includes an Advanced Hybrid Closed Loop (AHCL) algorithm which provides for both automated basal and correction bolus insulin delivery. The preliminary performance of the system in real-world settings was evaluated.

METHODS: Data uploaded from August 2020 to March 2021 by individuals living in Belgium, Finland, Italy, the Netherlands, Qatar, South Africa, Sweden, Switzerland and the United Kingdom were aggregated and retrospectively analyzed to determine the mean Glucose Management Indicator (GMI), percentage of time spent within (TIR), below (TBR) and above (TAR) glycemic ranges, system use and insulin consumption in users having ≥10 days of sensor glucose (SG) data after initiating AHCL. The impact of initiating AHCL was evaluated in a sub-group of users also having ≥10 days of SG data, before AHCL initiation.

RESULTS: Users (N=4120) were observed for a mean of 54±32 days. During this time, they spent a mean of 94.1±11.4% of the time in AHCL and achieved a mean GMI of 6.8±0.3%, TIR of 76.2±9.1%, TBR<70 of 2.5±2.1% and TAR>180 of 21.3±9.4%, after initiating AHCL. There were 77.3% and 79.0% of users who achieved a TIR >70% and a GMI of <7.0%, respectively. Users for which comparison with pre-AHCL was possible (N=812) reduced their GMI by 0.4±0.4% (p=0.005) and increased their TIR by 12.1±10.5% (p<0.0001), post-AHCL initiation. More users achieved the glycemic treatment goals of GMI <7.0% (37.6% vs 75.2%, p<0.0001) and TIR >70% (34.6% vs 74.9%, p<0.0001) when compared to pre-AHCL initiation.

CONCLUSION: Most MiniMed™ 780G system users achieved TIR >70% and GMI <7%, while minimizing hypoglycemia, in a real-world condition.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app